FAKTOR YANG MEMPENGARUHI PASIEN TUBERKULOSIS RESISTAN OBAT YANG TIDAK MEMULAI PENGOBATAN: LITERATURE REVIEW

Indri Rizkiyani, Syahrizal Syarif

Abstract


Drug-resistant tuberculosis (DR TB) patients who have been diagnosed but not enrolled to treatment could be a source of primary transmission and the risk of increasing DR TB cases in the community. The aim of this literature review is to determine the factors that influence pre-treatment lost to follow up of DR TB patients by searching the literature through Google Scholar, ScienceDirect, ProQuest and PubMed which was published in the period 2016 to 2023 with the keywords "drug resistant tuberculosis", "treatment initiation", “enrollment rate”, and “pre-treatment lost to follow up”. Seven articles were obtained of which three research articles came from China, two from South Africa, one from India, and one from Ethiopia. Factors that influence DR TB patients not starting treatment include age, economic status, drug sensitive TB treatment status, inadequate health service infrastructure, lack of experienced clinicians, health seeking behavior, and health system delays. The low rate of DR TB treatment initiation requires special attention, both in terms of health services provided by the government and support from the community, in order to break the chain of transmission in the community.


Keywords


Tuberkulosis Resistan Obat Inisiasi pengobatan Tidak berobat Enrollment Rate

Full Text:

PDF

References


WHO, "TB Global Report," WHO, Geneva, 2021.

Kementerian Kesehatan RI, "Laporan Tahunan Program TBC 2022," Kemenkes RI, Jakarta, 2023.

Kementerian Kesehatan RI, Petunjuk Teknis Pendampingan Pasien Tuberkulosis Resistan Obat oleh Komunitas, Jakarta: Kemenkes RI, 2020.

Najmah, Epidemiologi Untuk Mahasiswa Kesehatan Masyarakat, Depok: Rajawali Press, 2015.

Kementerian Kesehatan RI, Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat di Indonesia, Jakarta: Kemenkes RI, 2020.

Shaikh, Babar and J. Hatcher, "Health Seeking Behaviour and Health Services Utilization in Pakistan: Challenging The Policy Makers," Journal of Public Health, vol. 27, no. 1, pp. 49-54, 2004.

Y.-z. Ruan, R.-z. Li, J. Zhao, W. Su, J. Cheng, C.-y. Zhang, L.-x. Wang and Y. Hao, "The analysis of 119 cases of multidrug-resistant tuberculosis patients not enrolling for proper treatment in different financing models," Chinese Journal of Antituberculosis, vol. 36, no. 5, pp. 308-312, 2014.

X. Zuhui, X. Tao, L. Yanhong, Y. Kunyun, T. Yi and B. Liqiong, "Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China," Plos One, vol. 12, no. 1, 2017.

C. Xu, R. Li, H. Shewade, K. Jevashree, Y. Ruan and C. Zhang, "Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors," Plos One, vol. 14, no. 4, 2019.

H. Cox, H. Dickson, N. Ndjeka, A. Vanhoog, A. Grant and F. Colebens, "Delays and loss to follow-up before treatment of drug- resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study," Plos Med, vol. 14, no. 2, 2017.

B. Moore, L. Erasmus, J. Ershova, S. Smith, N. Ndjeka and L. Podewils, "Pre-treatment loss to follow-up among children with multidrug- resistant tuberculosis in South Africa, 2008–2010," Plos One, vol. 15, no. 4, 2020.

H. Shewade, K. Shringarpure, M. Parmar, S. Patel, S. Kuriya, S. Shihora, N. Ninama, N. Gosai, R. Khokhariya, C. Popat, H. Thanki, B. Modi, P. Dave, R. Baxi and A. Kumar, "Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India," Public Health Action, vol. 8, no. 2, 2018.

H. Tola, K. Holakouie-Naieni, M. Mansournia, M. Yaseri, E. Tesfaye and Z. Mahamed, "Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study," Plos One, vol. 15, no. 2, 2020.

A. Irdham and A. L. Barikha, "Faktor-faktor yang memengaruhi penduduk lanjut usia berobat jalan di Provinsi Jawa Timur," Jurnal Kependudukan Indonesia, vol. 17, no. 1, pp. 70-99, 2022.

Peraturan Presiden RI, "Peraturan Presiden RI tentang Penanggulangan Tuberkulosis nomor 67 tahun 2021," Perpres RI, Jakarta, 2021.

Kementerian Kesehatan RI, "Laporan Capaian Indikator Pendanaan Hibah Global Fund ATM Komponen TBC Periode Januari - Juni 2023," Kemenkes RI, Jakarta, 2023.

I. Abrori and R. A. Ahmad, "Kualitas hidup penderita tuberkulosis resisten obat di kabupaten Banyumas," Berita Kedokteran Masyarakat, vol. 34, no. 2, pp. 55-61, 2018.

WHO, WHO Consolidated Guidelines on Tuberculosis. Module 4: Drug-resistant tuberculosis treatment, 2022 update, Geneva: WHO, 2022.

D. Evans, T. Sineke, K. Schnippel, R. Berhanu and et al, "Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa," BMC Health Services Research, vol. 18, 2018.

A. S. Kurd, A. Wali, R. Fatima, A. Yaqoob, D. Khan and S. Lehri, "Pre-treatment loss to follow-up among patients with rifampicin-resistant tuberculosis in Baluchistan, Pakistan, 2012-17: a retrospective cohort study," F1000Research, 2019.

D. Evans, K. Schnippel, C. Govathson and et al, "Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa," Plos One, vol. 12, no. 7, 2017.

O. A. Adejumo, O. Daniel, V. A. Adepoju and et al, "Pretreatment attrition and treatment initiation delay among rifampicin-resistant tuberculosis patients in Lagos, Nigeria: a retrospective cohort study," Tropical Medicine & Hygiene, vol. 116, no. 12, pp. 1154-1161, 2022.

S. M. Deviernur and A. Nurhayati, "Analisis Survival: Hubungan Konversi Sputum dengan Keberhasilan Pengobatan Pasien Tuberkulosis Resistan Obat di Indonesia," Jurnal Epidemiologi Kesehatan Indonesia, vol. 7, no. 1, pp. 43-50, 2023.

B. Katende, T. M. Esterhuizen, A. Dippenaar and R. M. Warren, "Rifampicin Resistant tuberculosis in Lesotho: Diagnosis, treatment initiation and outcomes," Scientific Reports, vol. 1917, no. 10, 2020.

A. Amala and W. H. Cahyati, "Drop Out Pengobatan Pada Tuberkulosis Multidrug Resistant (TB MDR) di Kota Semarang," Quality: Jurnal Kesehatan, vol. 15, no. 1, pp. 24-36, 2021.




DOI: http://dx.doi.org/10.35329/jkesmas.v10i1.4973

Article Metrics

Abstract views : 235 times | PDF - 106 times


Copyright (c) 2024 J-KESMAS: Jurnal Kesehatan Masyarakat

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Alamat Penyunting & Distribusi:

Fakultas Kesehatan Masyarakat Universitas Al Asyariah Mandar  Gedung B3. Lt 1. Jl. Budi Utomo No.2 Manding. Kec. Polewali, Kab. Polewali Mandar, Prov. Sulawesi Barat

Email: jkesmanfkm@gmail.com

Website: https://journal.lppm-unasman.ac.id/index.php/jikm/index

Penerbit:
Lembaga Penelitian dan Pengabdian Masyarakat Universitas Al Asyariah Mandar


Indexed by:

           

   

Member of:

 

 

Creative Commons License
J-Kesmas is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.